Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases.
Portella L, Vitale R, De Luca S, D'Alterio C, Ieranò C, Napolitano M, Riccio A, Polimeno MN, Monfregola L, Barbieri A, Luciano A, Ciarmiello A, Arra C, Castello G, Amodeo P, Scala S.
Portella L, et al. Among authors: de luca s.
PLoS One. 2013 Sep 13;8(9):e74548. doi: 10.1371/journal.pone.0074548. eCollection 2013.
PLoS One. 2013.
PMID: 24058588
Free PMC article.